Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
by from Morbidity and Mortality Weekly Report (MMWR) on (#6D4VC)
This report describes respiratory syncytial virus (RSV) vaccine recommendations for adults 60 years and older.